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percutaneous coronary intervention (PCI) for ST-segment elevation acute myocardial infarction (STEMI)
in common practice.
Background Radial access for PCI has been studied considerably, but mostly in clinical trials.
Methods All patients undergoing PCI for STEMI in 2009 to 2010 in New York were studied to
determine the frequency and the patient-level predictors of radial access. Differences in in-hospital/
30-day mortality between radial and femoral access were also studied.
Results Radial access increased from 4.9% in the ﬁrst quarter of 2009 to 11.9% in the last quarter of
2010. Signiﬁcant independent predictors were higher body surface area, non-Hispanic ethnicity,
Caucasian race, stable hemodynamic state, ejection fraction <30% and 50% onset of STEMI from
12 to 23 h before the index procedure, and peripheral vascular disease. Mortality was not related to
access site after adjustment for covariates (for radial vs. femoral access, adjusted odds ratio: 0.86, 95%
conﬁdence interval: 0.59 to 1.25), but the radial access site was trending toward lower mortality for the
9 hospitals that used it for more than 10% of their patients (adjusted odds ratio: 0.61, 95% conﬁdence
interval: 0.36 to 1.02).
Conclusions The use of a radial access site for PCI in STEMI patients increased between 2009 and
2010, but was still infrequent in 2010, and was used for lower-risk STEMI patients. There was no
signiﬁcant difference in mortality by access site, but there was a trend toward a mortality advantage
for patients with a radial access site among hospitals that used it relatively frequently. (J Am Coll
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277In recent years, numerous studies have shown that the radial
artery is a safe and feasible alternative to the femoral artery as
a vascular access site for percutaneous coronary intervention
(PCI) and coronary angiography. Among the advantages of
radial artery access are lower bleeding and vascular compli-
cation rates and earlier discharge because there is no
requirement for post-procedural bed rest (1–3). This has also
resulted in lower costs (4). However, the transradial
approach to PCI is more technically demanding, and its
adoption in the United States has been slow despite the fact
that it is more commonly used in Asia and Europe (4,5).
More recently, numerous clinical trials and observational
studies have found superior outcomes for the radial ap-
proach, particularly for patients presenting with an acute
myocardial infarction (AMI) and for the subset of AMI
patients presenting with ST-segment elevation myocardial
infarction (STEMI) (1–21).
One purpose of this study was to examine the utilization
of the radial approach for patients undergoing PCI for
STEMI in New York State, including trends and variations
across hospitals in the utilization of the radial versus femoral
approaches. The study also identiﬁes patient factors that are
associated with higher use of the radial approach, compares
short-term (in-hospital/30-day) mortality after adjusting for
important differences between the 2 groups, and examines
differences in door-to-balloon times.
Methods
Databases. Data were obtained from New York State’s
Percutaneous Coronary Interventions Reporting System, a
mandatory registry in New York that was initially developed
in 1991. The registry contains detailed information about
each patient undergoing PCI in the state, including de-
mographics; pre-procedural risk factors; periprocedural
complications; types of devices used; extent of disease and
lesions treated; dates of admission, discharge, and procedure;
discharge disposition and destination; and hospital and
operator identiﬁers. There is also a variable that denotes the
access site (radial, femoral).
These data are matched to New York State administra-
tive data for purposes of auditing completeness and the
accuracy of in-hospital mortality reporting. Also, medical
records are audited by the New York State Department of
Health’s utilization review agent in order to ensure accuracy
of the reporting of risk factors and complications. Registry
records are matched to New York vital statistics data to
identify deaths after discharge within 30 days of the index
procedure.
Patients, hospitals, and outcomes. A total of 11,057 STEMI
patients with an onset-to-door time of <24 h who under-
went immediate primary or rescue PCI in nonfederal New
York hospitals between January 1, 2009, and December 31,
2010, were considered for the study. A total of 840 (7.6%)patients had radial access, 7 of whom had radial access fol-
lowed by femoral access (and were counted as radial access),
and 10,217 (92.4%) of whom had femoral access. Patients
were excluded if they had cardiogenic shock before or at the
time of the PCI.
All 67 hospitals in New York State in which PCI was
performed for STEMI were included in the study. The
primary outcomes studied were the use of a radial access site
and short-term mortality (in-hospital/30-day).
Statistical analysis. All analyses were conducted for the
group of STEMI patients mentioned in the preceding text.
First, the prevalence and percentage of patients undergoing
PCI with a radial access site were tracked in 3-month in-
tervals throughout the course of the study to identify the
relative frequency of radial access and to determine whether
the extent to which radial access was chosen increased
substantially during the course of the study period. Variation
in the use of radial access across hospitals was computed
after subdividing the percentage of patients with radial ac-
cess into relevant ranges.
The signiﬁcant bivariate pre-
dictors of radial access were
identiﬁed based on available in-
formation in the registry, which
included demographics (age, sex,
race, ethnicity), hemodynamic
state, ejection fraction, time from
onset of pre-procedural myocar-
dial infarction, Canadian Car-
diovascular Society class, type of
angina, and numerous comor-
bidities. Chi-square tests were
used for categorical variables, and
Wilcoxon rank sum tests were
used for continuous variables to determine whether there
was a signiﬁcantly higher prevalence of 1 type of access site
for each variable in comparison to the other type of access
site. Variables that were associated with a higher prevalence
of 1 of the types of access sites when in competition with all
other variables (i.e., signiﬁcant independent predictors of
access site) were identiﬁed by conducting a stepwise logistic
regression analysis with access site as the dependent variable,
and all signiﬁcant bivariate predictors (with p < 0.10) of
access site as candidate independent variables.
Bivariate differences in in-hospital/30-day mortality
between radial and femoral access were examined along
with the bivariate relationships with mortality of all of the
risk factors mentioned in the preceding text. Signiﬁcant
risk factors in the bivariate analyses (p < 0.10) were added
to access site in a stepwise logistic regression analysis with
generalized estimating equations to determine whether
access site was a signiﬁcant predictor of mortality after
controlling for the impact of signiﬁcant patient-level
risk factors. Generalized estimating equations were
infarction
Figure 1. PCI for STEMI Patients
Percent of STEMI patients with radial access PCI. PCI ¼ percutaneous coronary
intervention; STEMI ¼ ST-segment elevation myocardial infarction.
Figure 2. Range in Percent of PCI Patients With STEMI Who Had
Radial Access, by Number of Hospitals
New York State, January 2009 through December 2010. Abbreviations as in
Figure 1.
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278used to account for clustering of patients within hos-
pitals. Differences in door-to-balloon times were also
investigated.
All tests were 2-sided and conducted at the 0.05 level, and
all analyses were conducted in SAS version 9.1 (SAS
Institute, Cary, North Carolina).Results
The percentage of all STEMI patients undergoing PCI with
a radial access site rose monotonically during the course of
the study, from 4.9% in the ﬁrst quarter of 2009 to 11.9%
during the last quarter of 2010 (Fig. 1).
The variation across hospitals in the use of a radial access
site during the study period was considerable (Fig. 2).
Twelve (21%) of the 58 hospitals never used a radial access
site, 44 (76%) of the hospitals used a radial access site <5%
of the time, and 4 (7%) of the hospitals used radial access for
>30% of their PCIs. The post-procedural length of stay for
STEMI patients with radial access was signiﬁcantly lower
(3.6 days vs. 4.6 days, p < 0.0001).
Bivariate predictors of radial access for PCI for STEMI
patients were higher body surface area, non-Hispanic
ethnicity, race, stable hemodynamic state, higher and lower
ejection fractions, STEMIs with onset times from 6 to 23 h,
peripheral vascular disease, absence of malignant ventricular
arrhythmia, chronic obstructive pulmonary disease, low
creatinine levels, absence of multivessel disease, no previous
PCI or coronary artery bypass graft surgery, no previous
organ transplant, urgent priority, Canadian Cardiovascular
Society classes I, III, and IV, and unstable angina (Table 1).
Signiﬁcant independent predictors of radial access forSTEMI patients undergoing PCI in the logistic regression
model were higher body surface area, non-Hispanic
ethnicity, Caucasian race, stable hemodynamic state, ejection
fraction <30% and 50%, onset of STEMI between 12 and
23 h before the index procedure, and peripheral vascular
disease (Table 2).
With regard to mortality, in-hospital/30-day mortality for
all STEMI patients with radial access PCI was lower, but
not signiﬁcantly lower, than the mortality for their femoral
access counterparts (2.7% vs. 3.6%; p ¼ 0.21). Signiﬁcant
independent predictors of in-hospital/30-day mortality for
STEMI patients were older age, hemodynamic instability,
ejection fraction <30%, peripheral vascular disease, malig-
nant ventricular arrhythmia, chronic obstructive pulmonary
disease, current congestive heart failure, elevated creatinine
levels, renal dialysis, multivessel disease, and left main dis-
ease. After controlling for these risk factors, there was not a
signiﬁcant mortality difference by access site (for radial vs.
femoral access, adjusted odds ratio [AOR]: 0.86, 95%
conﬁdence interval [CI]: 0.59 to 1.25).
When the analyses were restricted to the 9 hospitals that
used radial access for 10% of their STEMI patients, radial
access was trending toward lower mortality in comparison to
femoral access in those 9 hospitals (AOR: 0.61, 95% CI:
0.36 to 1.02). These 9 hospitals used PCI with radial access
for 660 patients in total, and this constituted 31% of all PCIs
for their STEMI patients and 79% of all PCIs for STEMI
with radial access that were performed in the state in the
study period.
In the group of all 58 hospitals in the study, the respective
percentages of STEMI patients undergoing PCI with radial
or femoral access with door-to-balloon times <90 min were
72% and 77% (p ¼ 0.0006).
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The purpose of this study was to examine the use of radial
artery access for STEMI patients undergoing PCI in New
York in 2009 to 2010, including changes in use, patient
characteristics associated with radial access, and differences
in mortality between patients receiving radial and those
receiving femoral access.
With regard to utilization patterns, we found that there
was a substantial increase in the use of radial artery access for
PCI among STEMI patients (from 4.9% in the ﬁrst quarter
of 2009 to 11.9% in the last quarter of 2010). However, as
evidenced by these percentages, the conversion to radial
access is still quite modest, although it is somewhat higher in
New York than that reported in the United States based on
the NCDR (National Cardiovascular Data Registry) (6.4%
of STEMI patients received radial access in the third quarter
of 2011) (19). Clearly, disadvantages associated with radial
access (a longer learning curve and more technically
demanding) are still important considerations despite the
increase in its use.
It is also notable that there is considerable variation in
choice of arterial access site for AMI patients across hospi-
tals in the state. Although 76% of all hospitals used radial
access for AMI patients <5% of the time, and 21% of
hospitals never used it, there were 4 hospitals that used radial
access for >30% of their patients. Whether this is a sign of a
trend toward radial access across the state remains to be seen.
The signiﬁcant independent correlates of radial access
for STEMI patients were almost all related to lower risk
and nonminority status: higher body surface area, Caucasian
race, non-Hispanic ethnicity, hemodynamic instability,
higher and lower ejection fractions, STEMI within 12 to
23 h before the procedure, and peripheral vascular disease.
In comparison, Baklanov et al. (21) found younger age,
male sex, white race, peripheral vascular disease, recent heart
failure, and no prior AMI, PCI, coronary artery bypass graft
surgery, or dialysis to be associated with higher radial access
rates.
Thus, although our study pertained to high-risk patients
(STEMI), the subset of these patients undergoing radial
access was of lower risk than the group undergoing femoral
access. As a result of this, although the in-hospital/30-day
mortality rate for STEMI patients undergoing PCI with
radial access was somewhat lower than the rate for their
femoral access counterparts (2.7% vs. 3.6%; p ¼ 0.21), the
AOR for mortality of radial versus femoral access was not
signiﬁcant (AOR: 0.86, 95% CI: 0.59 to 1.25). However,
when the analyses were restricted to the 9 hospitals that used
radial access for 10% of their AMI patients, radial access
was trending toward lower mortality (AOR: 0.61, 95% CI:
0.36 to 1.02). Also, as noted earlier, there is no reason to
believe that these hospitals had superior outcomes in generalcompared with other hospitals because their overall risk-
adjusted mortality was not lower.
It should be noted that several randomized controlled
trials (RCTs) and observational studies found lower adverse
outcome rates for AMI patients undergoing PCI with radial
access. For example, in a meta-analysis of 9 RCTs consisting
of 2,977 STEMI patients undergoing PCI, Mamas et al. (6)
found that patients with radial access had signiﬁcantly lower
rates of mortality (odds ratio [OR]: 0.53, 95% CI: 0.33 to
0.84), major adverse cardiac events (OR: 0.62, 95% CI: 0.43
to 0.90), and access site complications (OR: 0.30, 95% CI:
0.19 to 0.48). Joyal et al. (7), in a meta-analysis of 10 RCTs
of primary PCI for STEMI with 3,347 patients, found that
the radial approach was associated with better survival
(OR: 0.53, 95% CI: 0.33 to 0.84), and a lower rate of
vascular complication/hematoma (OR: 0.35, 95% CI: 0.24
to 0.53). Jang et al. (1) performed a meta-analysis of 21
RCTs and observational studies for STEMI patients un-
dergoing PCI, and found that radial access was associated
with lower rates of major adverse cardiac events (OR: 0.56,
95% CI: 0.44 to 0.72), mortality (OR: 0.55, 95% CI: 0.42 to
0.72), and major bleeding (OR: 0.32, 95% CI: 0.22 to 0.48).
A large observational study by Baklanov et al. (21) using
NCDR data limited to STEMI patients found that patients
with radial access had signiﬁcantly lower in-hospital mor-
tality than patients with femoral access (AOR: 0.76, 95%
CI: 0.57 to 0.99; p ¼ 0.0455). The signiﬁcant ﬁndings
may have in part been related to the mortality measure used
in the study. When we repeated our study using only in-
hospital mortality rather than in-hospital/30-day mortality,
we also found that the radial access had signiﬁcantly lower ris-
k-adjusted mortality. However, we believe in-hospital/30-day
mortality is a better measure to use because of relatively high
short-term mortality rates for PCI patients after discharge.
Also, our study differed from the NCDR study in that our
study is population-based (it includes all patients undergoing
PCI in a large geographical region).
An observational study conducted in Italy by Valgimigli
et al. (14) found that radial access PCI was associated with
lower 2-year risk-adjusted mortality for STEMI patients
than femoral access PCI (8.8% vs. 11.4%; p ¼ 0.03).
However, it should be noted that 28% of all patients in the
study underwent PCI with radial access, so their ﬁndings
may be stronger in favor of radial access than ours because of
increased experience using the radial approach. When we
limited our study to hospitals using radial access for 10% of
their STEMI patients, we found that radial access was
trending toward signiﬁcantly lower in-hospital/30-day
mortality. This corresponds to the ﬁnding of Mehta et al.
(16) that there was a correlation between hospitals’ increased
use of radial access and better outcomes.
Study limitations. The primary study limitation is the use of
an observational database in order to compare mortality for
Table 1. Characteristics for 2009/2010 New York State AMI Patients With STEMI Undergoing PCI,





n ¼ 840 (7.6%)
Femoral Access
n ¼ 10,217 (92.4%) p Value
Age, yrs
50 2,616 (23.7) 199 (23.7) 2.417 (23.7)
51–55 1,673 (15.1) 144 (17.1) 1,529 (15.0)
56–60 1,745 (15.8) 141 (16.8) 1,604 (15.7)
61–65 1,470 (13.3) 116 (13.8) 1,354 (13.2)
66–70 1,134 (10.3) 76 (9.0) 1,058 (10.4)
71–75 848 (7.7) 62 (7.4) 786 (7.7)
76–80 713 (6.4) 48 (5.7) 665 (6.5)
81–85 512 (4.6) 38 (4.5) 474 (4.6)
86þ 346 (3.1) 16 (1.9) 330 (3.2) 0.2848
Sex
Male 8,095 (73.2) 614 (73.1) 7,481 (73.2)
Female 2,962 (26.8) 226 (26.9) 2.736 (26.8) 0.9369
Body surface area, m2 2.03  0.26 2.10  0.29 2.02  0.26 <0.0001
Ethnicity
Hispanic 1,216 (11.0) 38 (4.5) 1,178 (11.5)
Non-Hispanic 9,841 (89.0) 802 (95.5) 9,039 (88.5) <0.0001
Race
White 9,019 (81.6) 762 (90.7) 8,257 (80.8)
Black 1,052 (9.5) 51 (6.1) 1,001 (9.8)
Asian 606 (5.5) 15 (1.8) 591 (5.8)
Other 380 (3.4) 12 (1.4) 368 (3.6) <0.0001
Hemodynamic state
Stable 10,708 (96.8) 831 (98.9) 9,877 (96.7)
Unstable 349 (3.2) 9 (1.1) 340 (3.3) 0.0003
Ejection fraction, %
<20 140 (1.3) 14 (1.7) 126 (1.2)
20–29 726 (6.6) 64 (7.6) 662 (6.5)
30–39 1,559 (14.1) 117 (13.9) 1,442 (14.1)
40–49 2,939 (26.6) 185 (22.0) 2,754 (27.0)
50 4,025 (36.4) 391 (46.6) 3,634 (35.6)
Ejection fraction missing 1,668 (15.1) 69 (8.2) 1,599 (15.6) <0.0001
Pre-procedural MI with ST-segment elevation
<6 h before 8,428 (76.2) 591 (70.4) 7,837 (76.7)
6–11 h before 1,685 (15.2) 143 (17.0) 1,542 (15.1)
12–23 h before 944 (8.5) 106 (12.6) 838 (8.2) <0.0001
Peripheral vascular disease
Yes 450 (4.1) 60 (7.1) 390 (3.8)
No 10,607 (95.9) 780 (92.9) 9,827 (96.2) <0.0001
Cerebrovascular disease
Yes 484 (4.4) 35 (4.2) 449 (4.4)
No 10,573 (95.6) 805 (95.8) 9,768 (95.6) 0.7562
Malignant ventricular arrhythmia
Yes 248 (2.2) 11 (1.3) 237 (2.3)
No 10,809 (97.8) 829 (98.7) 9,980 (97.7) 0.0574
COPD
Yes 470 (4.2) 47 (5.6) 423 (4.1)
No 10,587 (95.8) 793 (94.4) 9,794 (95.9) 0.0445
Continued on the next page
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n ¼ 840 (7.6%)
Femoral Access
n ¼ 10,217 (92.4%) p Value
Diabetes
Yes 2,153 (19.5) 151 (18.0) 2,002 (19.6)
No 8,904 (80.5) 689 (82.0) 8,215 (80.4) 0.2548
Congestive heart failure
Current 448 (4.0) 30 (3.6) 418 (4.1)
Past 105 (1.0) 9 (1.1) 96 (0.9)
None 10,504 (95.0) 801 (95.4) 9,703 (95.0) 0.7147
Renal failure, mg/dl
Creatinine <1.2 7,739 (70.0) 613 (73.0) 7,126 (69.8)
Creatinine 1.2–1.5 2,475 (22.4) 186 (22.1) 2,289 (22.4)
Creatinine 1.6–2.0 539 (4.9) 29 (3.4) 510 (5.0)
Creatinine 2.1–2.5 121 (1.1) 7 (0.8) 114 (1.1)
Creatinine 2.6 87 (0.8) 1 (0.1) 86 (0.8)
Dialysis 96 (0.9) 4 (0.5) 92 (0.9) 0.0311
Vessels diseased
None 50 (0.4) 7 (0.8) 43 (0.4)
1 6,012 (54.4) 494 (58.8) 5,518 (54.0)
2 3,399 (30.7) 242 (28.8) 3,157 (30.9)
3 1,596 (14.4) 97 (11.6) 1,499 (14.7) 0.0057
Left main disease
Yes 301 (2.7) 23 (2.7) 278 (2.7)
No 10,756 (97.3) 817 (97.3) 9,939 (97.3) 0.9766
Previous PCI(s)
Yes 1,937 (17.5) 126 (15.0) 1,811 (17.7)
No 9,120 (82.5) 714 (85.0) 8,406 (82.3) 0.0458
Previous CABG surgery
Yes 443 (4.0) 20 (2.4) 423 (4.1)
No 10,614 (96.0) 820 (97.6) 9,794 (95.9) 0.0124
Stent thrombosis
Yes 517 (4.7) 31 (3.7) 486 (4.8)
No 10,540 (95.3) 809 (96.3) 9,731 (95.2) 0.1594
Emergency PCI*
Yes 7 (0.1) 1 (0.1) 6 (0.1)
No 11,050 (99.9) 839 (99.9) 10,211 (99.9) 0.5040
Any previous organ transplant
Yes 35 (0.3) 0 (0.0) 35 (0.3)
No 11,022 (99.7) 840 (100.0) 10,182 (99.7) 0.0893
Priority
Elective 36 (0.3) 1 (0.1) 35 (0.3)
Urgent 512 (4.6) 62 (7.4) 450 (4.4)
Emergency 10,509 (95.0) 777 (92.5) 9,732 (95.2) 0.0002
CCS class
I 52 (0.5) 9 (1.1) 43 (0.4)
II 322 (2.9) 17 (2.0) 305 (3.0)
III 402 (3.6) 49 (5.8) 353 (3.5)
IV 4,975 (45.0) 420 (50.0) 4,555 (44.6)
None 5,306 (48.00) 345 (41.1) 4,961 (48.6) <0.0001
Angina
Stable 167 (1.5) 10 (1.2) 157 (1.5)
Unstable 5,585 (50.5) 486 (57.9) 5,099 (49.9)
None 5,305 (48.0) 344 (41.0) 4,961 (48.6) <0.0001
Values are n (%) or mean  SD. *Due to a complication of the diagnostic catheterization.
AMI ¼ acute myocardial infarction; CABG ¼ coronary artery bypass graft; CCS ¼ Canadian Cardiovascular Society; COPD ¼ chronic obstructive
pulmonary disease; MI ¼ myocardial infarction; PCI ¼ percutaneous coronary intervention; STEMI ¼ ST-segment elevation myocardial infarction.
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Table 2. Logistic Regression Model for Signiﬁcant Independent Predictors of Radial Access for PCI for
STEMI Patients in New York State in 2009/2010 (N ¼ 11,057)*
Risk Factor Coefﬁcient (95% CI) Odds Ratio (95% CI)
p Value
(Multivariable)
Body surface area 0.8726 (0.5171–1.2282) 2.393 (1.677–3.415) <0.0001
Non-Hispanic 0.9536 (0.3768–1.5305) 2.595 (1.458–4.620) 0.0012
White race 0.8084 (0.4784–1.1383) 2.244 (1.613–3.121) <0.0001
Stable hemodynamic state 1.1486 (0.4602–1.8371) 3.154 (1.584–6.278) 0.0011
Ejection fraction, %
0–29 0.5427 (0.2247–0.8607) 1.721 (1.252–2.365) 0.0008
50 0.5468 (0.1909–0.9026) 1.728 (1.210–2.466) 0.0026
Pre-procedural MI with STEMI within 12 to 23 h 0.5359 (0.2465–0.8252) 1.709 (1.280–2.282) 0.0003
Peripheral vascular disease 0.7633 (0.2887–1.2380) 2.145 (1.335–3.449) 0.0016
*Intercept ¼ 7.3670.
CI ¼ conﬁdence interval; other abbreviations as in Table 1.
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282patients with radial and femoral access. This can lead to the
chance of unmeasured confounding because of variables not
available in our database that may have been a factor in the
choice of arterial access that were also related to in-hospital/
30-day mortality. Typical ways of minimizing this bias
include propensity matching of patients and controlling for
variables available in the observational database using multi-
variable statistical models. We chose the latter approach via
a logistic regression model. Nevertheless, unmeasured con-
founding is possible, and may have contributed to our ﬁnding
that although radial access was associated with lower mor-
tality than femoral access, it was not signiﬁcantly lower.
Another limitation of our study is that we did not have access
to data on bleeding, which has been demonstrated to have
lower rates among radial access patients (21).
Also, only 7 patients were reported as crossovers from
radial access to femoral access, and because our analyses were
based on intention to treat, and crossover probably has worse
outcomes on average, unreported crossovers will bias the
results against femoral access patients.
Conclusions
The use of a radial access site for PCI in STEMI patients
increased between 2009 and 2010, but was still infrequent in
2010, and was used for lower-risk STEMI patients. There
was no signiﬁcant difference in mortality by access site, but
there was a trend toward a mortality advantage for patients
with a radial access site among hospitals that used it rela-
tively frequently.
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